Coreg CR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Coreg Cr, and what generic alternatives are available?
Coreg Cr is a drug marketed by Woodward and is included in one NDA. There is one patent protecting this drug and three Paragraph IV challenges.
This drug has twenty-four patent family members in fourteen countries.
The generic ingredient in COREG CR is carvedilol phosphate. There are thirty-seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Coreg Cr
A generic version of Coreg CR was approved as carvedilol phosphate by SUN PHARM INDUSTRIES on October 25th, 2017.
Summary for Coreg CR
International Patents: | 24 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 31 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for Coreg CR |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for Coreg CR |
What excipients (inactive ingredients) are in Coreg CR? | Coreg CR excipients list |
DailyMed Link: | Coreg CR at DailyMed |
Pharmacology for Coreg CR
Drug Class | alpha-Adrenergic Blocker beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic alpha-Antagonists Adrenergic beta1-Antagonists Adrenergic beta2-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for Coreg CR
Paragraph IV (Patent) Challenges for COREG CR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
COREG CR | Extended-release Capsules | carvedilol phosphate | 10 mg and 20 mg | 022012 | 1 | 2008-03-18 |
COREG CR | Extended-release Capsules | carvedilol phosphate | 40 mg | 022012 | 1 | 2007-12-21 |
COREG CR | Extended-release Capsules | carvedilol phosphate | 80 mg | 022012 | 1 | 2007-11-19 |
US Patents and Regulatory Information for Coreg CR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-001 | Oct 20, 2006 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-004 | Oct 20, 2006 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-002 | Oct 20, 2006 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-003 | Oct 20, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Coreg CR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-004 | Oct 20, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-004 | Oct 20, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-002 | Oct 20, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-002 | Oct 20, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Coreg CR
See the table below for patents covering Coreg CR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 314830 | ⤷ Try a Trial | |
Germany | 19503995 | Verwendung von Carvedilol zur Verminderung der Mortalität bei Patienten mit eingeschränkter myocardialer Funktion | ⤷ Try a Trial |
China | 1568181 | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles | ⤷ Try a Trial |
Russian Federation | 2197242 | СПОСОБ СНИЖЕНИЯ СМЕРТНОСТИ В РЕЗУЛЬТАТЕ ЗАСТОЙНОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ С ПРИМЕНЕНИЕМ КАРВЕДИЛОЛА (METHOD FOR DECREASING A LETHALITY RATE AS A RESULT OF A STATIC HEART FAILURE BY USING CARVEDILOL) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |